Why did CVS and Aetna merger?

CVS Health acquired Aetna for $69 billion in 2018 to create a vertically integrated healthcare giant that combines retail pharmacies, pharmacy benefit management (PBM), and health insurance.

Key Strategic Motivations

• Lower Healthcare Costs: CVS aimed to curb rising medical expenses by shifting routine care and chronic disease management into lower-cost settings like local CVS storefronts and MinuteClinics.
• Connecting Data and Care: The merger allowed the company to merge pharmacy prescription records with medical insurance data to better coordinate patient care and prevent hospital visits.
• Expanding Preventative Services: CVS utilized Aetna's roughly 22 million medical members to drive traffic into its nearly 10,000 retail locations and walk-in clinics.
• Financial Synergies: The deal targeted over $750 million in cost savings and operational synergies within the first two years.
• Defending Against Market Threats: The acquisition helped position CVS to fend off new competitive threats from retail and tech disruptors like Amazon, as well as massive health conglomerates like UnitedHealth.

Doctors and healthcare systems leave Aetna's network primarily due to disagreements over reimbursement rates, heavy administrative burdens, and failed contract negotiations.

For comprehensive details on why provider networks change, you can review the Aetna Medicare Provider Network Changes guide.

Key Reasons Providers Leave Aetna

• Low Reimbursement Rates: Providers often state that Aetna's payment rates do not keep up with inflation, rising operational costs, or the rates paid by other insurers.
• Administrative Hassles: Doctors face extensive paperwork, prior authorization (precertification) requirements, and claim denials that increase office overhead and delay care.
• Contract Impasses: When annual or multi-year contracts expire, Aetna and large medical groups (such as university health systems or regional hospitals) frequently fail to agree on financial terms, forcing providers out-of-network.
• Aetna's Market Reductions: Parent company CVS Health has pulled back from specific regional markets, scaling back certain Affordable Care Act (ACA) exchange footprints and Medicare Advantage plans, which structurally alters local networks.

The controversy surrounding CVS Health's acquisition of Aetna spans from initial antitrust battles during their massive $69 billion merger in 2018 to multi-million dollar fraud settlements and legal challenges regarding consumer care.

The primary areas of controversy involve:

1. Antitrust Concerns and Market Dominance (2018–2019)

The landmark vertical merger combined CVS Caremark (one of the nation's largest pharmacy benefit managers, or PBMs) and CVS retail pharmacies with Aetna (a giant health insurer). This triggered heavy resistance:

• The Elimination of Competition: Major watchdogs, including the American Medical Association (AMA) and the American Antitrust Institute (AAI), fiercely opposed the deal. They argued it would form an anticompetitive PBM oligopoly, leading to higher premiums, lower quality of care, fewer consumer choices, and the potential to squeeze out independent pharmacies.
• The Divestiture Compromise: To appease the U.S. Department of Justice (DOJ), Aetna was forced to divest its entire individual Medicare Part D prescription drug plan business to WellCare Health Plans.
• Judicial Pushback: In an unusual move, U.S. District Judge Richard Leon initially refused to rubber-stamp the settlement. He held rare public hearings to scrutinize the deal and expressed concerns that the DOJ was not doing enough to protect the public interest, though he ultimately approved it in September 2019.

2. Overbilling and Medicare Advantage Fraud (2026 Settlement)

In March 2026, CVS's Aetna unit agreed to pay $117.7 million to the U.S. government to resolve a federal whistleblower lawsuit.

• The Allegations: The DOJ accused Aetna of violating the False Claims Act by knowingly submitting inaccurate diagnosis codes (such as for morbid obesity) for its Medicare Advantage enrollees between 2018 and 2023.
• The Mechanism: By submitting sicker diagnosis codes, Aetna allegedly artificially inflated its patient risk scores to manipulate the government into providing higher monthly reimbursement payments. Aetna denied liability but settled to avoid litigation costs.

3. Systematic Care Denials via AI Algorithms (2026 Lawsuit)

Aetna faces significant backlash from class-action investor lawsuits alleging the company secretly deployed AI algorithms to systematically deny expensive requests for post-acute medical care.

• According to the legal actions, the algorithm rejected care claims on a massive scale based on financial cost rather than actual medical necessity.
• Critics state that this practice artificially inflated the reported financial health of CVS's health care benefits segment until congressional investigations and new federal regulations forced them to phase out the program.

4. Conflict of Interest and Whistleblower Claims

During the initial merger finalization, internal whistleblowers exposed deeper conflicts of interest. Notably, Aetna's chief Medicare actuary filed a lawsuit alleging that CVS Caremark had been heavily overbilling Medicare Part D plans for prescription drugs. Aetna subsequently engaged in a fierce legal battle to suppress its own employee's evidence and claw back records to keep the details hidden from the reviewing courts.

CVS owns Aetna, but it does not own Cigna.

CVS and Aetna

• Acquisition: CVS Health bought Aetna in late 2018 for roughly $69 billion.
• Operation: Aetna operates as a subsidiary and a health insurance brand under the CVS Health corporate umbrella.

Cigna

• Independence: Cigna (The Cigna Group) is a separate, publicly traded competitor.
• Different Partner: Cigna owns its own pharmacy benefit manager called Express Scripts rather than being tied to CVS.

Aetna is cancelling and scaling back dozens of Medicare Advantage plans primarily due to rising medical utilization costs and inadequate government reimbursements from the Centers for Medicare & Medicaid Services (CMS) that fail to keep pace with inflation.

Most users on Reddit agree that increasing care costs and profitability challenges are driving major insurers like Aetna, Humana, and UnitedHealthcare to retreat from unprofitable markets.

📊 Key Drivers Behind Aetna's Cuts

• 📈 Rising Medical Costs: Higher-than-expected doctor visits, procedures, and post-pandemic care utilization have strained insurer margins.
• 📉 Lower Government Payments: CMS benchmark updates and reimbursement rates have not kept up with inflation or care costs.
• 📌 Profitability & Footprint Reduction: Aetna is withdrawing or trimming options (especially PPO plans) across dozens of states to focus on sustainable service areas.
• 🔍 Broker Commission Adjustments: Aetna and other carriers have cut or halted broker commissions on specific plans to manage acquisition expenses.